ACOR - Using the Action in Acorda Therapeutics to our Advantage

Our job as investors is to pay attention to the stocks we own.  Part of that involves looking at the fundamentals, but half of the disclosure comes from looking at price action. The Acorda Therapeutics (NASDAQ: ACOR) data table below can help you with price action, and we have more details too. Trading plans for ACOR are shown here too; these plans are updated in real time for subscribers, where this report is static. If you want an update, or a report on a different stock, please get one here Unlimited Real Time Reports .

Technical Summary

Long Term Trading Plans for ACOR

March 14, 2021, 3:15 pm ET

The Technical Summary and Trading Plans for ACOR help you determine where to buy, sell, and set risk controls. The data is best used in conjunction with our Market Analysis and Stock Correlation Filters too, because those help us go with the flow of the market as well. Going with the flow is extremely important, so review our Market Analysis with this ACOR Report.

ACOR - (Long) Support Plan

The technical summary data tells us to buy ACOR near 5.26 with an upside target of 7.13. This data also tells us to set a stop loss @ 5.24 to protect against excessive loss in case the stock begins to move against the trade. 5.26 is the first level of support below 5.86 , and by rule, any test of support is a buy signal. In this case, support 5.26 is being tested, a buy signal would exist.

ACOR - (Short) Resistance Plan

The technical summary data is suggesting a short of ACOR as it gets near 7.13 with a downside target of 5.26. We should have a stop loss in place at 7.15though. 7.13 is the first level of resistance above 5.86, and by rule, any test of resistance is a short signal. In this case, if resistance 7.13 is being tested, a short signal would exist.